We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$236M
(+65%)
Cap. Flow
+$223M
Cap. Flow
% of AUM
37.19%
Top 10 Holdings %
Top 10 Hldgs %
44.46%
Holding
172
New
111
Increased
19
Reduced
6
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$67.1M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$18.3M |
| 3 |
HHLA.U
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
|
+$16.7M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$16.2M |
| 5 |
Grindr
GRND
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SINA
Sina Corp
SINA
|
+$98.5M |
| 2 |
TINV.U
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
|
+$11.3M |
| 3 |
Alibaba
BABA
|
+$9.75M |
| 4 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$9.42M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$9.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.15% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 8.54% |
| 4 | Communication Services | 8.31% |
| 5 | Industrials | 3.54% |
Similar funds
THCM
WG
FAL
AIA
DMC
KL
UOC
MFA
Athos Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Athos Capital held 172 positions worth $599M, up 65% from $363M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Athos Capital deployed $223M of net new capital in Q1 2021, opening 111 new positions and adding to 19 existing holdings. Its largest new stake was IHS Markit Ltd. Common Shares: 199,800 shares worth $19.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Maxim Integrated Products, an estimated $4.58M trimmed.
- Athos Capital's largest Q1 2021 buy was IHS Markit Ltd. Common Shares: 199,800 shares worth $19.3M.
- Athos Capital added most to China Biologic Products Holdings, Inc. in Q1 2021, an estimated $67.1M increase.
- Athos Capital's biggest Q1 2021 reduction was Maxim Integrated Products, cutting an estimated $4.58M.
- Athos Capital fully exited Sina Corp in Q1 2021, selling an estimated $98.5M.
- Athos Capital's ten largest holdings make up 44% of its $599M portfolio in Q1 2021.
- Athos Capital opened 111 new positions and closed 33 in Q1 2021.
- Athos Capital's portfolio value rose 65% quarter-over-quarter to $599M.
Based on Athos Capital's 13F filing for Q1 2021, filed 14 May 2021.